
Blog|Articles|February 9, 2022
Interactive Case Study in Migraine Prevention
Advertisement
We invite you to navigate through the treatment journey of a patient living with migraine.
Explore the individual patient outcomes and learn about the efficacy and safety of a monoclonal antibody for the preventive treatment of migraine.
This program is intended for US audiences only. This program is not approved for continuing medical education (CME) credit. ©2022. Lundbeck. All rights reserved. MIG-D-100153.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
CTAD Presentation Lays Insights Into Disappointing Phase 3 EVOKE Trial of GLP-1 Semaglutide in Alzheimer Disease
2
Merck’s Novel Antibody MK-2214 Receives FDA Fast-Track Designation Following Phase 1 Results
3
Epidiolex CBD Treatment Effective Across Range of Developmental Epileptic Encephalopathies
4
US Survey Reveals Underuse of Dravet Syndrome–Specific Antiseizure Medications in the Clinic
5


































